THEREMIA raises 3 million euros to personalize medical treatments
THEREMIA is a French deeptech company specializing in precision medicine. It has developed an artificial intelligence platform allowing medical treatments to be personalized according to the specificities of each patient. By adjusting parameters such as frequency, dosage and drug formulation, Theremia seeks to improve the effectiveness of treatments while reducing side effects, a central objective … Read more